Treatment

• Non-Small Cell Lung Cancer Treatment (PDQ®)
  [ patient ] [ health professional ]
  Expert-reviewed information summary about the treatment of non-small cell lung cancer.
• Clinical Trials to Treat Non-Small Cell Lung Cancer
  Check for non-small cell lung cancer treatment trials from NCI's list of cancer clinical trials now accepting patients. The list of clinical trials can be refined by location, stage of disease, drug, and other features.
• Small Cell Lung Cancer Treatment (PDQ®)
  [ patient ] [ health professional ]
  Expert-reviewed information summary about the treatment of small cell lung cancer.
• Clinical Trials to Treat Small Cell Lung Cancer
  Check for small cell lung cancer treatment trials from NCI's list of cancer clinical trials now accepting patients. The list of clinical trials can be refined by location, stage of disease, drug, and other features.
• Drugs Approved for Lung Cancer
  This page lists cancer drugs approved by the Food and Drug Administration (FDA) for lung cancer. The list includes generic names, brand names, and common drug combinations, which are shown in capital letters.
• Cetuximab Plus Chemotherapy Extends Survival for Advanced Lung Cancer
  Patients with advanced non-small-cell lung cancer (NSCLC) who received cetuximab (Erbitux) plus chemotherapy lived on average 5 weeks longer than patients who received chemotherapy alone, according to results of a randomized phase III trial.
• Crizotinib Continues to Show Promise for Some Lung Tumors, Faces Challenge of Drug Resistance
  New data from a phase I trial of crizotinib, a small-molecule drug that targets cancer-causing chromosomal rearrangements involving the gene ALK, in patients with non-small cell lung cancer add to positive results presented at the 2010 American Society of Clinical Oncology annual meeting.
• For Lung Cancer, a New Drug and a Way Forward
  Non-small cell lung cancer patients with the EML4/ALK fusion gene have a high likelihood of responding to ALK-targeted agents, such as the drug, crizotinib.
• Palliative Care Improves Survival, Quality of Life in Advanced Lung Cancer
  Patients with advanced lung cancer who received early palliative care experienced longer median survival than those who only received palliative care near death, according to results of a randomized clinical trial published August 19, 2010, in the New England Journal of Medicine.
• New Lung Cancer Treatment Approach Raises Hopes and Debate
  Several recent phase III trials have shown some success using maintenance therapy, that is, extending the duration of initial treatment, when treating advanced non-small cell lung cancer patients.
• Angiogenesis Inhibitors
  A fact sheet that describes the process of eliminating the blood supply to tumors. Lists the cancers in which this approach is being tested.
• Biological Therapies for Cancer
  A fact sheet that provides an overview of how the immune system functions and describes the actions of biological therapies.
• Lasers in Cancer Treatment
  A fact sheet that describes use of high-intensity light in cancer treatment, its advantages and disadvantages, and types of procedures that use it.
• Photodynamic Therapy for Cancer
  A fact sheet that explains photodynamic therapy, how it is administered, and indications and side effects of treatment.
• Radiation Therapy for Cancer
  A fact sheet that defines the different types of radiation therapy and discusses scientific advances that improve the effectiveness of this treatment.
• Targeted Cancer Therapies
  A fact sheet that describes targeted cancer therapies, which are drugs that block the growth and spread of cancer by interfering with specific molecules involved in carcinogenesis (the process by which normal cells are transformed into cancer cells) and tumor growth.
• Metastatic Cancer
  A fact sheet about metastasis, the spread of cancer to other parts of the body. Discusses the diagnosis and treatment of cancer that has spread.